AstraZeneca’s global biologics research and development arm MedImmune...
London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm, completed its acquisition of Amplimmune,...
View ArticleAstraZeneca and MedImmune presented encouraging results from their novel...
LONDON, 2-6-2015 — /EuropaWire/ — AstraZeneca and MedImmune, the company’s global biologics research and development arm, today presented encouraging results from their novel combination-focused...
View Article
More Pages to Explore .....
